Pub Date : 2025-12-23eCollection Date: 2025-01-01DOI: 10.5114/bta/214377
Diana Mikiewicz, Anna Mazurkiewicz-Pisarek, Magdalena Janczewska, Jolien De Waele, Alina Mazurkiewicz, Agata Stefanek, Frank Bosmans, Agnieszka Lew-Mirska, Przemysław Styczeń, Tomasz Ciach
Background: Conotoxins are small peptides known for their potent and selective activity on ion channels, offering potential applications in both medicine and cosmetology. This study aimed to design and validate recombinant conotoxin TIIIA and its mutant TIIIAlaMut, assess their biological activity on the voltage-gated Na+ (Nav) channel Nav1.4, and evaluate the antiwrinkle efficacy of a topical cream containing the recombinant peptide in a group of volunteers.
Materials and methods: Fusion genes encoding TRX::TIIIA and TRX::TIIIAlaMut were cloned into the pDM vector and expressed in Escherichia coli S4B cells. The proteins were purified using Ni-NTA chromatography, cleaved with CNBr under optimized acidic conditions, and analyzed. Biological activity was assessed using two-electrode voltage-clamp electrophysiology in Xenopus laevis oocytes expressing the human Nav1.4 channel. Additionally, a conotoxin-containing cream was applied to 55 human volunteers in an application study assessing its antiaging effects.
Results: Both recombinant genes were successfully expressed, purified, and activated. Electrophysiological measurements demonstrated their ability to inhibit Nav1.4 channel activity, including the version extracted directly from the cream. In the human study, 47% of participants reported a visible reduction in wrinkles. Additional benefits included evening of skin tone, reduced erythema, and balanced sebum production in oily skin types.
Conclusion: This study describes the design, bacterial expression, and functional analysis of recombinant conotoxins TIIIA and TIIIAlaMut. Their bioactivity was confirmed on human Nav1.4 channels. The recombinant toxins, including the form extracted from the cream, showed effects comparable to a synthetic standard. Application tests demonstrated the conotoxin's potential in cosmeceuticals, particularly in reducing periocular wrinkles and improving skin texture and tone.
{"title":"Gene expression, purification, and functional characterization of recombinant conotoxin μ-TIIIA and TIIIAlaMut in <i>Escherichia coli</i> with clinical evaluation of antiwrinkle efficacy.","authors":"Diana Mikiewicz, Anna Mazurkiewicz-Pisarek, Magdalena Janczewska, Jolien De Waele, Alina Mazurkiewicz, Agata Stefanek, Frank Bosmans, Agnieszka Lew-Mirska, Przemysław Styczeń, Tomasz Ciach","doi":"10.5114/bta/214377","DOIUrl":"10.5114/bta/214377","url":null,"abstract":"<p><strong>Background: </strong>Conotoxins are small peptides known for their potent and selective activity on ion channels, offering potential applications in both medicine and cosmetology. This study aimed to design and validate recombinant conotoxin TIIIA and its mutant TIIIAlaMut, assess their biological activity on the voltage-gated Na<sup>+</sup> (Nav) channel Nav1.4, and evaluate the antiwrinkle efficacy of a topical cream containing the recombinant peptide in a group of volunteers.</p><p><strong>Materials and methods: </strong>Fusion genes encoding <i>TRX::TIIIA</i> and <i>TRX::TIIIAlaMut</i> were cloned into the pDM vector and expressed in <i>Escherichia coli</i> S4B cells. The proteins were purified using Ni-NTA chromatography, cleaved with CNBr under optimized acidic conditions, and analyzed. Biological activity was assessed using two-electrode voltage-clamp electrophysiology in <i>Xenopus laevis</i> oocytes expressing the human Nav1.4 channel. Additionally, a conotoxin-containing cream was applied to 55 human volunteers in an application study assessing its antiaging effects.</p><p><strong>Results: </strong>Both recombinant genes were successfully expressed, purified, and activated. Electrophysiological measurements demonstrated their ability to inhibit Nav1.4 channel activity, including the version extracted directly from the cream. In the human study, 47% of participants reported a visible reduction in wrinkles. Additional benefits included evening of skin tone, reduced erythema, and balanced sebum production in oily skin types.</p><p><strong>Conclusion: </strong>This study describes the design, bacterial expression, and functional analysis of recombinant conotoxins TIIIA and TIIIAlaMut. Their bioactivity was confirmed on human Nav1.4 channels. The recombinant toxins, including the form extracted from the cream, showed effects comparable to a synthetic standard. Application tests demonstrated the conotoxin's potential in cosmeceuticals, particularly in reducing periocular wrinkles and improving skin texture and tone.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 4","pages":"397-410"},"PeriodicalIF":0.0,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: As society rapidly ages, the escalating global demand for natural, high-value antioxidants - particularly ketocarotenoids such as canthaxanthin - is driving intensive research into their sustainable bioproduction. This study investigates the potential of the green microalga Chlorosarcinopsis PY02 as a novel microbial cell factory for enhanced ketocarotenoid production under abiotic stress conditions.
Materials and methods: We optimized bioprocess parameters using a simple, spot-test-based high-throughput screening technique, evaluating algal growth and pigment accumulation on tris acetate phosphate agar supplemented with various sodium chloride concentrations (0-15 g/l).
Results: Peak canthaxanthin content (294.55 µg/g dry weight) was observed at 10 g/l NaCl, while biomass yield was highest at 12 g/l. Combining salt stress with a 50% nitrogen reduction increased total carotenoid productivity (highest with 10 g/l NaCl: 3.10 mg/l) but did not enhance canthaxanthin levels; the salt-only treatment produced the highest canthaxanthin yield (0.80 mg/l). Pigment identification and quantitative profiling were performed using thin-layer chromatography and spectrophotometry, confirming the efficiency of the production process.
Conclusions: These findings highlight Chlorosarcinopsis PY02 as a promising candidate for sustainable, large-scale production of ketocarotenoids. The study also demonstrates a cost-effective and scalable approach for inducing carotenoid biosynthesis in Chlorosarcinopsis PY02, with strong relevance for sustainable pigment production. The simple visual screening method provides a practical tool for preliminary strain and condition optimization in microalgal bioprocess development.
{"title":"Salinity-driven canthaxanthin enhancement in <i>Chlorosarcinopsis</i> PY02: a practical spot test for microalgal bioprocess optimization.","authors":"Thanyanan Wannathong Brocklehurst, Nipawan Puedsing, Theera Thurakit, Phinyarat Sensupa, Saranyaporn Maksap, Orawan Borirak","doi":"10.5114/bta/214478","DOIUrl":"10.5114/bta/214478","url":null,"abstract":"<p><strong>Background: </strong>As society rapidly ages, the escalating global demand for natural, high-value antioxidants - particularly ketocarotenoids such as canthaxanthin - is driving intensive research into their sustainable bioproduction. This study investigates the potential of the green microalga <i>Chlorosarcinopsis</i> PY02 as a novel microbial cell factory for enhanced ketocarotenoid production under abiotic stress conditions.</p><p><strong>Materials and methods: </strong>We optimized bioprocess parameters using a simple, spot-test-based high-throughput screening technique, evaluating algal growth and pigment accumulation on tris acetate phosphate agar supplemented with various sodium chloride concentrations (0-15 g/l).</p><p><strong>Results: </strong>Peak canthaxanthin content (294.55 µg/g dry weight) was observed at 10 g/l NaCl, while biomass yield was highest at 12 g/l. Combining salt stress with a 50% nitrogen reduction increased total carotenoid productivity (highest with 10 g/l NaCl: 3.10 mg/l) but did not enhance canthaxanthin levels; the salt-only treatment produced the highest canthaxanthin yield (0.80 mg/l). Pigment identification and quantitative profiling were performed using thin-layer chromatography and spectrophotometry, confirming the efficiency of the production process.</p><p><strong>Conclusions: </strong>These findings highlight <i>Chlorosarcinopsis</i> PY02 as a promising candidate for sustainable, large-scale production of ketocarotenoids. The study also demonstrates a cost-effective and scalable approach for inducing carotenoid biosynthesis in <i>Chlorosarcinopsis</i> PY02, with strong relevance for sustainable pigment production. The simple visual screening method provides a practical tool for preliminary strain and condition optimization in microalgal bioprocess development.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 4","pages":"421-430"},"PeriodicalIF":0.0,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17eCollection Date: 2025-01-01DOI: 10.5114/bta/214378
Sri Chandana Mavulati, Sujatha Dodoala
Background: Polycystic ovary syndrome (PCOS) affects millions of women worldwide and is primarily known for its reproductive and hormonal symptoms. However, growing evidence suggests a strong link between PCOS and inflammation. Rheumatoid arthritis (RA) and osteoarthritis (OA) similarly involve systemic inflammation and immune dysregulation. Despite their distinct clinical manifestations, these disorders may share overlapping biological pathways. This study aimed to identify shared transcriptomic signatures between PCOS and autoimmune joint diseases such as RA and OA.
Materials and methods: RNA sequencing datasets were downloaded from the publicly available Gene Expression Omnibus (GEO) database. After processing and quality filtering, a total of 73 samples from the GSE277906 and GSE89408 datasets were selected. DEG analysis was conducted using the DE-Seq2 package in RStudio by adjusting for a significant p-value < 0.1 and |log2 fold change| > 0.5. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to determine functional enrichment of genes and common pathways associated with the diseases.
Results: A total of 10,492 and 9,892 DEGs were identified in PCOS vs. RA and PCOS vs. OA, respectively. Key genes dysregulated among the diseases included TOMM34, DHCR24, CMAS, RBP1, and HSD3B2, and the enrichment analysis revealed overlapping pathways involving immune regulation, mitochondrial dysfunction, oxidative stress, and proteasome activity. Notably, 201 GO pathways were shared by PCOS and OA, 123 by RA and OA, and 267 by PCOS and RA. All three conditions shared a set of 57 GO pathways, including mitophagy and ER stress.
Conclusion: The identified common pathways signify the overlap between PCOS, RA, and OA. These findings support the hypothesis of systemic immunometabolic involvement in PCOS.
背景:多囊卵巢综合征(PCOS)影响着全世界数百万妇女,主要以其生殖和激素症状而闻名。然而,越来越多的证据表明多囊卵巢综合征和炎症之间有着密切的联系。类风湿关节炎(RA)和骨关节炎(OA)同样涉及全身炎症和免疫失调。尽管有不同的临床表现,这些疾病可能有重叠的生物学途径。本研究旨在确定PCOS与自身免疫性关节疾病(如RA和OA)之间共享的转录组特征。材料和方法:RNA测序数据集从公开的Gene Expression Omnibus (GEO)数据库下载。经过处理和质量滤波,从GSE277906和GSE89408数据集中共选择73个样本。使用RStudio中的DE-Seq2软件包进行DEG分析,调整p值< 0.1和|log2倍变化| > 0.5。进行基因本体(GO)和京都基因与基因组百科全书(KEGG)分析,以确定与疾病相关的基因功能富集和常见途径。结果:PCOS与RA和PCOS与OA分别鉴定出10,492和9,892个deg。这些疾病中出现异常的关键基因包括TOMM34、DHCR24、CMAS、RBP1和HSD3B2,富集分析揭示了涉及免疫调节、线粒体功能障碍、氧化应激和蛋白酶体活性的重叠通路。值得注意的是,PCOS和OA共有201条GO通路,RA和OA共有123条,PCOS和RA共有267条。这三种情况共有57种氧化石墨烯途径,包括有丝分裂和内质网应激。结论:PCOS、RA和OA的共同通路存在重叠。这些发现支持了多囊卵巢综合征系统免疫代谢参与的假设。
{"title":"Integrated gene expression analysis identifies shared inflammatory and metabolic pathways in polycystic ovarian syndrome, rheumatoid arthritis, and osteoarthritis.","authors":"Sri Chandana Mavulati, Sujatha Dodoala","doi":"10.5114/bta/214378","DOIUrl":"10.5114/bta/214378","url":null,"abstract":"<p><strong>Background: </strong>Polycystic ovary syndrome (PCOS) affects millions of women worldwide and is primarily known for its reproductive and hormonal symptoms. However, growing evidence suggests a strong link between PCOS and inflammation. Rheumatoid arthritis (RA) and osteoarthritis (OA) similarly involve systemic inflammation and immune dysregulation. Despite their distinct clinical manifestations, these disorders may share overlapping biological pathways. This study aimed to identify shared transcriptomic signatures between PCOS and autoimmune joint diseases such as RA and OA.</p><p><strong>Materials and methods: </strong>RNA sequencing datasets were downloaded from the publicly available Gene Expression Omnibus (GEO) database. After processing and quality filtering, a total of 73 samples from the GSE277906 and GSE89408 datasets were selected. DEG analysis was conducted using the DE-Seq2 package in RStudio by adjusting for a significant <i>p</i>-value < 0.1 and |log<sub>2</sub> fold change| > 0.5. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to determine functional enrichment of genes and common pathways associated with the diseases.</p><p><strong>Results: </strong>A total of 10,492 and 9,892 DEGs were identified in PCOS vs. RA and PCOS vs. OA, respectively. Key genes dysregulated among the diseases included <i>TOMM34, DHCR24, CMAS, RBP1</i>, and <i>HSD3B2</i>, and the enrichment analysis revealed overlapping pathways involving immune regulation, mitochondrial dysfunction, oxidative stress, and proteasome activity. Notably, 201 GO pathways were shared by PCOS and OA, 123 by RA and OA, and 267 by PCOS and RA. All three conditions shared a set of 57 GO pathways, including mitophagy and ER stress.</p><p><strong>Conclusion: </strong>The identified common pathways signify the overlap between PCOS, RA, and OA. These findings support the hypothesis of systemic immunometabolic involvement in PCOS.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 4","pages":"387-396"},"PeriodicalIF":0.0,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08eCollection Date: 2025-01-01DOI: 10.5114/bta/213740
Zuzanna Pyc, Rafal Rygiel, Dagmara Michalowska, Marcin Ekiert, Izabela Laczmanska
Molecular profiling has become a cornerstone of cancer diagnosis and treatment, with BRAF alterations serving as significant markers across various tumor types. The gene encodes a serine/threonine kinase involved in the MAPK/ERK signaling pathway, which regulates cell proliferation and survival. Mutations in BRAF, notably the V600 codon substitutions, are among the most common genetic drivers in melanoma and other cancers, including thyroid, colorectal, and non-small cell lung cancer. BRAF mutations are categorized into three functional classes (class I-III), each with distinct activation mechanisms and therapeutic implications. Current targeted therapies - primarily BRAF and MEK inhibitors, including the first FDA-approved anti-BRAF tumor-agnostic therapy - are most effective in cancers harboring the class I V600E mutation. However, the emergence of resistance to BRAF inhibitors has driven the development of next-generation inhibitors and combination treatments. Furthermore, innovative immunotherapy-based treatments have demonstrated synergistic potential in specific BRAF-mutated malignancies. Accurate molecular diagnostics are crucial in cancer treatment; therefore, numerous molecular diagnostic methods are employed, including next-generation sequencing (NGS), quantitative PCR, droplet digital PCR, Sanger sequencing, and fluorescence in situ hybridization (FISH). NGS, particularly comprehensive genomic profiling, provides the broadest and most detailed genetic data, although simpler laboratory techniques remain popular due to their accessibility and straightforward protocols. Further research into resistance mechanisms and combination therapies, as well as the integration of circulating tumor DNA (ctDNA) in diagnostics, is needed to fully realize the potential of personalized treatment in BRAF-driven tumors.
{"title":"Targeting <i>BRAF</i> in cancers - from molecular diagnostics to personalized therapy.","authors":"Zuzanna Pyc, Rafal Rygiel, Dagmara Michalowska, Marcin Ekiert, Izabela Laczmanska","doi":"10.5114/bta/213740","DOIUrl":"10.5114/bta/213740","url":null,"abstract":"<p><p>Molecular profiling has become a cornerstone of cancer diagnosis and treatment, with <i>BRAF</i> alterations serving as significant markers across various tumor types. The gene encodes a serine/threonine kinase involved in the MAPK/ERK signaling pathway, which regulates cell proliferation and survival. Mutations in <i>BRAF</i>, notably the V600 codon substitutions, are among the most common genetic drivers in melanoma and other cancers, including thyroid, colorectal, and non-small cell lung cancer. <i>BRAF</i> mutations are categorized into three functional classes (class I-III), each with distinct activation mechanisms and therapeutic implications. Current targeted therapies - primarily BRAF and MEK inhibitors, including the first FDA-approved anti-<i>BRAF</i> tumor-agnostic therapy - are most effective in cancers harboring the class I V600E mutation. However, the emergence of resistance to BRAF inhibitors has driven the development of next-generation inhibitors and combination treatments. Furthermore, innovative immunotherapy-based treatments have demonstrated synergistic potential in specific <i>BRAF</i>-mutated malignancies. Accurate molecular diagnostics are crucial in cancer treatment; therefore, numerous molecular diagnostic methods are employed, including next-generation sequencing (NGS), quantitative PCR, droplet digital PCR, Sanger sequencing, and fluorescence <i>in situ</i> hybridization (FISH). NGS, particularly comprehensive genomic profiling, provides the broadest and most detailed genetic data, although simpler laboratory techniques remain popular due to their accessibility and straightforward protocols. Further research into resistance mechanisms and combination therapies, as well as the integration of circulating tumor DNA (ctDNA) in diagnostics, is needed to fully realize the potential of personalized treatment in <i>BRAF</i>-driven tumors.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 4","pages":"431-440"},"PeriodicalIF":0.0,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848866/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Soil contamination by oil products is a significant problem that affects the environment, agriculture, economy, and human health, and requires effective solutions. The study aimed to develop effective methods of bioremediation of oil-contaminated soils using microbial preparation D (a mixture of Rhodococcus sp. and Gordonia sp. - a consortium of autochthonous hydrocarbon-degrading micro-organisms), a rhamnolipid biocomplex (RBC), the oxidant calcium peroxide (CaO2), and plant remediants.
Materials and methods: Bioremediation processes were carried out on oil-contaminated clay soil (initial contamination - 9.5%) over 1.5 years. First, the soil was treated with microbial preparation D and CaO2. After 14 days, field peas or sorghum were sown, with seeds treated using an RBC solution. Hydrogen peroxide content and lipid peroxidation index in plants, as well as soil dehydrogenase activity, were determined by spectrophotometry. Additionally, soil phytotoxicity was assessed using test plants, and the residual content of oil products was quantified.
Results: The best effect was achieved with the combined use of microbial preparation D, RBC, and CaO2: the degree of oil contamination in the soil decreased to 1.3%; with microbial preparation D, plants, and RBC, contamination decreased to 1.4-1.6% (compared to the initial 9.5%). The maximum value of dehydrogenase activity was recorded when sorghum, microbial preparation D, and RBC were applied, 2.7 times higher than in the control. After bioremediation, the phytotoxicity of oil-contaminated soils (in test plants) decreased on average by 3.7 times compared to the control.
Conclusion: The effectiveness of the integrated use of hydrocarbon-degrading microorganisms, field peas, sorghum, RBC, and CaO2 in bioremediation of oil-contaminated soils was established.
{"title":"Use of biosurfactants, microorganism-destructors, and plants for eco-friendly bioremediation technologies on oil-contaminated soils.","authors":"Andriy Banya, Oleksandr Karpenko, Tetyana Pokynbroda, Olena Karpenko, Vira Lubenets","doi":"10.5114/bta/209980","DOIUrl":"10.5114/bta/209980","url":null,"abstract":"<p><strong>Background: </strong>Soil contamination by oil products is a significant problem that affects the environment, agriculture, economy, and human health, and requires effective solutions. The study aimed to develop effective methods of bioremediation of oil-contaminated soils using microbial preparation D (a mixture of <i>Rhodococcus</i> sp. and <i>Gordonia</i> sp. - a consortium of autochthonous hydrocarbon-degrading micro-organisms), a rhamnolipid biocomplex (RBC), the oxidant calcium peroxide (CaO<sub>2</sub>), and plant remediants.</p><p><strong>Materials and methods: </strong>Bioremediation processes were carried out on oil-contaminated clay soil (initial contamination - 9.5%) over 1.5 years. First, the soil was treated with microbial preparation D and CaO<sub>2</sub>. After 14 days, field peas or sorghum were sown, with seeds treated using an RBC solution. Hydrogen peroxide content and lipid peroxidation index in plants, as well as soil dehydrogenase activity, were determined by spectrophotometry. Additionally, soil phytotoxicity was assessed using test plants, and the residual content of oil products was quantified.</p><p><strong>Results: </strong>The best effect was achieved with the combined use of microbial preparation D, RBC, and CaO<sub>2</sub>: the degree of oil contamination in the soil decreased to 1.3%; with microbial preparation D, plants, and RBC, contamination decreased to 1.4-1.6% (compared to the initial 9.5%). The maximum value of dehydrogenase activity was recorded when sorghum, microbial preparation D, and RBC were applied, 2.7 times higher than in the control. After bioremediation, the phytotoxicity of oil-contaminated soils (in test plants) decreased on average by 3.7 times compared to the control.</p><p><strong>Conclusion: </strong>The effectiveness of the integrated use of hydrocarbon-degrading microorganisms, field peas, sorghum, RBC, and CaO<sub>2</sub> in bioremediation of oil-contaminated soils was established.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 4","pages":"411-420"},"PeriodicalIF":0.0,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-06eCollection Date: 2025-01-01DOI: 10.5114/bta/209978
Sonam Yadav, Jaishiv, Rohit Kumar
Nanotechnology has emerged as a promising field with the potential to revolutionize several industries, including the food industry. It offers innovative solutions to critical challenges in food, such as safety, nutrition, waste reduction, and sustainability. This study examines the possibilities offered by nanotechnology in the food sector, with a focus on risk assessment, safety evaluation, and regulatory approaches. While nanotechnology in food applications presents many advantages, it also raises concerns about potential health risks. Due to their distinct characteristics, nanoparticles may interact with living organisms in unpredictable ways, creating challenges for risk assessment and management. This review also explores the possible hazards of using nanomaterials in the food system, highlighting the need for comprehensive toxicity studies and effective regulatory frameworks. Addressing these issues requires a multidisciplinary approach involving collaboration among scientists, regulators, policy-makers, and stakeholders to balance the benefits and risks of nanotechnology in the food system. As the food sector seeks novel approaches to meet rising global demand, it is crucial to thoroughly assess both the advantages and risks of nanotechnology to ensure its responsible and sustainable application while protecting human health and the environment.
{"title":"Nanotechnology in food systems: opportunities and risks for human health.","authors":"Sonam Yadav, Jaishiv, Rohit Kumar","doi":"10.5114/bta/209978","DOIUrl":"10.5114/bta/209978","url":null,"abstract":"<p><p>Nanotechnology has emerged as a promising field with the potential to revolutionize several industries, including the food industry. It offers innovative solutions to critical challenges in food, such as safety, nutrition, waste reduction, and sustainability. This study examines the possibilities offered by nanotechnology in the food sector, with a focus on risk assessment, safety evaluation, and regulatory approaches. While nanotechnology in food applications presents many advantages, it also raises concerns about potential health risks. Due to their distinct characteristics, nanoparticles may interact with living organisms in unpredictable ways, creating challenges for risk assessment and management. This review also explores the possible hazards of using nanomaterials in the food system, highlighting the need for comprehensive toxicity studies and effective regulatory frameworks. Addressing these issues requires a multidisciplinary approach involving collaboration among scientists, regulators, policy-makers, and stakeholders to balance the benefits and risks of nanotechnology in the food system. As the food sector seeks novel approaches to meet rising global demand, it is crucial to thoroughly assess both the advantages and risks of nanotechnology to ensure its responsible and sustainable application while protecting human health and the environment.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 4","pages":"441-460"},"PeriodicalIF":0.0,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Changes in biomolecules under the influence of chemical and physical factors on cells, tissues, and whole organisms are investigated.
Materials and methods: In vitro-incubated bovine embryonic cells were inoculated with low titers (high dilutions of viral suspensions) of vaccine avipoxviral strains. Mouse embryonic fibroblasts were co-cultivated with mouse malignant myeloma cells (P3-X63-Ag8) transfected by recombinant DNA plasmid or preincubated in culture fluid from prior incubation of the same cells. Sub-populations of virus-inoculated, co-cultivated, and preincubated cell cultures were frozen in the presence of the cryoprotectant dimethylsulfoxide (DMSO), subsequently thawed, and re-incubated. Newly formed cell monolayers were inoculated with extracellular and intracellular forms of each viral strain, both before and after exposure to DMSO and drastic temperature changes. Extracellular forms were derived from the cultural fluids of inoculated cell cultures, while intracellular forms were obtained from suspensions of mechanically scraped virus-inoculated cells.
Results: Exchange of nucleotide (DNA and/or RNA) fragments between cellular and viral genomes, as well as between genomes of separate cells, was suggested. These changes were explained by activated fusion induced by the organic detergent (DMSO) combined with drastic temperature changes. Such processes could provide vectors for gene-engineering manipulations and the development of molecular (DNA-based, RNA-based, and/or protein-based) antiviral and antimalignant vaccines. Production of immune molecules by nonimmune cell types under appropriate conditions, such as the presence of immunomodulators, was also proposed.
Conclusions: The results suggest the possibility of nucleotide (DNA and/or RNA) fragment exchange between separate cells, as well as between cells and virions. Nonimmune cells demonstrated the capacity to produce immune molecules under appropriate conditions.
{"title":"Investigation of materials for the development of new molecular and cellular antiviral and antimalignancy vaccines and immunization methods: a pilot study.","authors":"Iskra Sainova, Vera Kolyovska, Radka Hadjiolova, Andrey Petrov, Dimitrina Dimitrova-Dikanarova, Tzvetanka Markova","doi":"10.5114/bta/210359","DOIUrl":"10.5114/bta/210359","url":null,"abstract":"<p><strong>Background: </strong>Changes in biomolecules under the influence of chemical and physical factors on cells, tissues, and whole organisms are investigated.</p><p><strong>Materials and methods: </strong><i>In vitro</i>-incubated bovine embryonic cells were inoculated with low titers (high dilutions of viral suspensions) of vaccine avipoxviral strains. Mouse embryonic fibroblasts were co-cultivated with mouse malignant myeloma cells (P3-X63-Ag8) transfected by recombinant DNA plasmid or preincubated in culture fluid from prior incubation of the same cells. Sub-populations of virus-inoculated, co-cultivated, and preincubated cell cultures were frozen in the presence of the cryoprotectant dimethylsulfoxide (DMSO), subsequently thawed, and re-incubated. Newly formed cell monolayers were inoculated with extracellular and intracellular forms of each viral strain, both before and after exposure to DMSO and drastic temperature changes. Extracellular forms were derived from the cultural fluids of inoculated cell cultures, while intracellular forms were obtained from suspensions of mechanically scraped virus-inoculated cells.</p><p><strong>Results: </strong>Exchange of nucleotide (DNA and/or RNA) fragments between cellular and viral genomes, as well as between genomes of separate cells, was suggested. These changes were explained by activated fusion induced by the organic detergent (DMSO) combined with drastic temperature changes. Such processes could provide vectors for gene-engineering manipulations and the development of molecular (DNA-based, RNA-based, and/or protein-based) antiviral and antimalignant vaccines. Production of immune molecules by nonimmune cell types under appropriate conditions, such as the presence of immunomodulators, was also proposed.</p><p><strong>Conclusions: </strong>The results suggest the possibility of nucleotide (DNA and/or RNA) fragment exchange between separate cells, as well as between cells and virions. Nonimmune cells demonstrated the capacity to produce immune molecules under appropriate conditions.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 4","pages":"379-386"},"PeriodicalIF":0.0,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-22eCollection Date: 2025-01-01DOI: 10.5114/bta/209760
Archana Srivastava, Aruna Joshi
Background: Synthetic colors are widely used in the food and cosmetic industries to make products more appealing to consumers. However, the health hazards associated with synthetic colors have prompted their replacement with natural colors. Portulaca grandiflora is a promising candidate for natural color extraction, as it is rich in betalains. This study presents a reliable, reproducible three-step regeneration protocol for this plant and analyzes its betalain content.
Materials and methods: In vitro shoot cultures were established on Murashige and Skoog (MS) medium supplemented with different plant growth regulators. Anatomical studies were conducted to determine the stages of shoot primordium development. Betalains were extracted from in vivo plants using 60% methanol and subjected to spectrophotometric analysis. The effect of sodium ascorbate on betalain stability was also evaluated.
Results: Juvenile leaf explants regenerated shoots on MS medium supplemented with 10 μM 6-benzyladenine and 5 μM indole-3-acetic acid. Shoots were multiplied with 20 μM BA (6.25 ± 0.85 shoots/explant), and elongation was achieved with 5 μM gibberellic acid (GA3) (8.2 ± 0.37 shoots/explant). Shoot primordia developed from well-organized meristemoid cells. The betalain content in the stem was 26.66 ± 0.19 mg/100 g, but this pigment degraded within 24 h (42.19% degradation). The addition of 50 mM sodium ascorbate prevented betalain degradation, even after 24 h.
Conclusion: This study reports a regeneration protocol from juvenile leaf explants and demonstrates that betalain stability in the stem can be maintained with 50 mM sodium ascorbate.
{"title":"<i>In vitro</i> regeneration of <i>Portulaca grandiflora</i> Hook. and analysis of betalain content within <i>in vivo</i> plants.","authors":"Archana Srivastava, Aruna Joshi","doi":"10.5114/bta/209760","DOIUrl":"10.5114/bta/209760","url":null,"abstract":"<p><strong>Background: </strong>Synthetic colors are widely used in the food and cosmetic industries to make products more appealing to consumers. However, the health hazards associated with synthetic colors have prompted their replacement with natural colors. <i>Portulaca grandiflora</i> is a promising candidate for natural color extraction, as it is rich in betalains. This study presents a reliable, reproducible three-step regeneration protocol for this plant and analyzes its betalain content.</p><p><strong>Materials and methods: </strong><i>In vitro</i> shoot cultures were established on Murashige and Skoog (MS) medium supplemented with different plant growth regulators. Anatomical studies were conducted to determine the stages of shoot primordium development. Betalains were extracted from <i>in vivo</i> plants using 60% methanol and subjected to spectrophotometric analysis. The effect of sodium ascorbate on betalain stability was also evaluated.</p><p><strong>Results: </strong>Juvenile leaf explants regenerated shoots on MS medium supplemented with 10 μM 6-benzyladenine and 5 μM indole-3-acetic acid. Shoots were multiplied with 20 μM BA (6.25 ± 0.85 shoots/explant), and elongation was achieved with 5 μM gibberellic acid (GA<sub>3</sub>) (8.2 ± 0.37 shoots/explant). Shoot primordia developed from well-organized meristemoid cells. The betalain content in the stem was 26.66 ± 0.19 mg/100 g, but this pigment degraded within 24 h (42.19% degradation). The addition of 50 mM sodium ascorbate prevented betalain degradation, even after 24 h.</p><p><strong>Conclusion: </strong>This study reports a regeneration protocol from juvenile leaf explants and demonstrates that betalain stability in the stem can be maintained with 50 mM sodium ascorbate.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 3","pages":"291-308"},"PeriodicalIF":0.0,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145380577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-22eCollection Date: 2025-01-01DOI: 10.5114/bta/208778
Demy Valerie Chacon, Kiana Alika Co, Daphne Noreen Enriquez, Aubrey Love Labarda, Reanne Eden Manongsong, Edward Kevin Bragais
Background: Helicobacter pylori infects approximately half of the global population, leading to gastric and duodenal ulcers. Despite the availability of antibiotics, challenges such as patient reluctance, high treatment costs, and antibiotic resistance limit their effectiveness, making vaccination a promising alternative. This study used immunoinformatics to identify candidate epitopes for a multiepitope vaccine construct against H. pylori.
Materials and methods: The protein variability server was utilized for conservation analysis. The epitopes were screened for antigenicity, allergenicity, toxicity, cross-reactivity, and population coverage. Selected epitopes were docked with their corresponding human leukocyte antigen (HLA) alleles, and thermodynamic quantities were determined. Five virulence factors - HopZ, SabA, HP-NAP, OipA, and urease - were selected for their critical roles in bacterial adhesion, immune modulation, and stress survival.
Results: Conservation analysis revealed a highly conserved protein sequence (Shannon index ≤ 0.1). The predicted epitopes had an IC50 value of ≤ 500 nM, indicating strong binding to the corresponding HLAs, with an estimated population coverage of more than 90% in the Southeast Asian region. The predicted epitopes were identified as probable nonallergens, nontoxic, and noncross-reactive (E value >1.0). Molecular docking analysis showed that the candidate epitopes could bind strongly and spontaneously with their corresponding HLA proteins, as evidenced by low negative Gibbs free energy (ΔG) values and dissociation constants (KD < 100 nM).
Conclusion: The epitopes predicted from the five virulence factors present promising candidates for future H. pylori vaccine design. Further in vitro and in vivo experiments are recommended to validate these preliminary findings.
背景:幽门螺杆菌感染了大约一半的全球人口,导致胃和十二指肠溃疡。尽管可以获得抗生素,但患者不愿意、高昂的治疗费用和抗生素耐药性等挑战限制了它们的有效性,使疫苗接种成为一种有希望的替代方案。本研究利用免疫信息学方法鉴定了一种针对幽门螺杆菌的多表位疫苗结构的候选表位。材料和方法:利用蛋白质变异服务器进行保守性分析。筛选表位的抗原性、过敏原性、毒性、交叉反应性和人群覆盖率。选择的表位与相应的人类白细胞抗原(HLA)等位基因对接,并测定热力学量。五种毒力因子- HopZ, SabA, HP-NAP, OipA和脲酶-被选中,因为它们在细菌粘附,免疫调节和应激生存中起着关键作用。结果:保守分析显示该蛋白序列高度保守(Shannon指数≤0.1)。预测的表位IC50值≤500 nM,表明与相应hla结合较强,估计东南亚地区的种群覆盖率超过90%。预测的表位被鉴定为可能的非过敏原,无毒,无交叉反应(E值>1.0)。分子对接分析表明,候选表位可以与相应的HLA蛋白自发结合,具有较低的负吉布斯自由能(ΔG)值和解离常数(K D < 100 nM)。结论:五种毒力因子预测的表位为未来幽门螺杆菌疫苗设计提供了有希望的候选表位。建议进行进一步的体外和体内实验来验证这些初步发现。
{"title":"<i>In silico</i> prediction of cytotoxic T-cell epitopes from <i>Helicobacter pylori</i> virulence factors using an immunoinformatics approach.","authors":"Demy Valerie Chacon, Kiana Alika Co, Daphne Noreen Enriquez, Aubrey Love Labarda, Reanne Eden Manongsong, Edward Kevin Bragais","doi":"10.5114/bta/208778","DOIUrl":"10.5114/bta/208778","url":null,"abstract":"<p><strong>Background: </strong><i>Helicobacter pylori</i> infects approximately half of the global population, leading to gastric and duodenal ulcers. Despite the availability of antibiotics, challenges such as patient reluctance, high treatment costs, and antibiotic resistance limit their effectiveness, making vaccination a promising alternative. This study used immunoinformatics to identify candidate epitopes for a multiepitope vaccine construct against <i>H. pylori</i>.</p><p><strong>Materials and methods: </strong>The protein variability server was utilized for conservation analysis. The epitopes were screened for antigenicity, allergenicity, toxicity, cross-reactivity, and population coverage. Selected epitopes were docked with their corresponding human leukocyte antigen (HLA) alleles, and thermodynamic quantities were determined. Five virulence factors - HopZ, SabA, HP-NAP, OipA, and urease - were selected for their critical roles in bacterial adhesion, immune modulation, and stress survival.</p><p><strong>Results: </strong>Conservation analysis revealed a highly conserved protein sequence (Shannon index ≤ 0.1). The predicted epitopes had an IC<sub>50</sub> value of ≤ 500 nM, indicating strong binding to the corresponding HLAs, with an estimated population coverage of more than 90% in the Southeast Asian region. The predicted epitopes were identified as probable nonallergens, nontoxic, and noncross-reactive (<i>E</i> value >1.0). Molecular docking analysis showed that the candidate epitopes could bind strongly and spontaneously with their corresponding HLA proteins, as evidenced by low negative Gibbs free energy (ΔG) values and dissociation constants (<i>K</i> <sub>D</sub> < 100 nM).</p><p><strong>Conclusion: </strong>The epitopes predicted from the five virulence factors present promising candidates for future <i>H. pylori</i> vaccine design. Further <i>in vitro</i> and <i>in vivo</i> experiments are recommended to validate these preliminary findings.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 3","pages":"241-258"},"PeriodicalIF":0.0,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-12eCollection Date: 2025-01-01DOI: 10.5114/bta/208621
Anhelina Kyrychenko
In this review, I describe recent findings on the molecular architecture and genomic characterization of giant viruses that infect microbial eukaryotes (protists) across diverse ecosystems and ecological niches. Giant viruses are distinguished by their large and complex genomes, which encode a wide range of functions, including protein translation, carbohydrate and lipid metabolism, nitrogen cycling, light assimilation, and key metabolic pathways such as glycolysis and the tricarboxylic acid cycle. Additionally, these genomes feature unique genes, often acquired through horizontal gene transfer, that are not found in other viruses and contribute to the viruses' ability to manipulate host metabolism and evade host defenses. A core set of genes conserved across different families of giant viruses is highlighted, serving as essential components for key life-cycle processes and providing valuable phylogenetic markers. The review also discusses the role of ORFans and virophages in contributing to the genetic diversity and evolutionary adaptation of these viruses. These findings are crucial for understanding the diversity, evolutionary mechanisms, and complex virus-host interactions of giant viruses, as well as for developing more advanced classification systems. Furthermore, the potential biotechnological applications of unique viral genes and pathways are explored, underscoring the importance of ongoing research in this field.
{"title":"Molecular architecture of giant viruses infecting microbial eukaryotes (protists).","authors":"Anhelina Kyrychenko","doi":"10.5114/bta/208621","DOIUrl":"10.5114/bta/208621","url":null,"abstract":"<p><p>In this review, I describe recent findings on the molecular architecture and genomic characterization of giant viruses that infect microbial eukaryotes (protists) across diverse ecosystems and ecological niches. Giant viruses are distinguished by their large and complex genomes, which encode a wide range of functions, including protein translation, carbohydrate and lipid metabolism, nitrogen cycling, light assimilation, and key metabolic pathways such as glycolysis and the tricarboxylic acid cycle. Additionally, these genomes feature unique genes, often acquired through horizontal gene transfer, that are not found in other viruses and contribute to the viruses' ability to manipulate host metabolism and evade host defenses. A core set of genes conserved across different families of giant viruses is highlighted, serving as essential components for key life-cycle processes and providing valuable phylogenetic markers. The review also discusses the role of ORFans and virophages in contributing to the genetic diversity and evolutionary adaptation of these viruses. These findings are crucial for understanding the diversity, evolutionary mechanisms, and complex virus-host interactions of giant viruses, as well as for developing more advanced classification systems. Furthermore, the potential biotechnological applications of unique viral genes and pathways are explored, underscoring the importance of ongoing research in this field.</p>","PeriodicalId":94371,"journal":{"name":"Biotechnologia","volume":"106 3","pages":"361-376"},"PeriodicalIF":0.0,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550674/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145380601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}